DB2-98941-85834
3 vaccinations
5 coded responses
37 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 467 / IN
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-01-02
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Diarrhea · Be unable to do your normal daily activitiesFree text: Slight runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-05
- 2021-01-06
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-23
- 2021-01-24
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-26
- 2021-01-27
- 2021-02-04
-
2021-02-12
Survey response — day 21, dose 2MedDRA: Headache, Nausea — Feeling: GoodFree text: Increased headaches, and off and on again nausea.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-24
-
2021-03-05
Survey response — day 42, dose 2MedDRA: Headache — Feeling: FairFree text: More frequent headaches.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-07-21
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-04
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Aphonia, Body temperature increased, Ear pain, Headache, Nasal congestion, Nausea, Obstructive airways disorder, Oropharyngeal pain, Productive cough, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested positive for covid 19 on 12/27/21. Sore throat Congestion (nose and throat mainly)- coughing up phlegm, blocks airway sometimes Loss of voice Headache Fever 99.8 that morning Nausea Ears hurtMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-04
-
2022-01-04
Call successfulCompleted over the phone
- 2022-04-01
- 2022-10-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
VAERS report filed, before or during a call: 1
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Slight runny nose
Release 4 — day 21, dose 2
Symptoms: Increased headaches, and off and on again nausea.
Release 5 — day 42, dose 2
Symptoms: More frequent headaches.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat
Release 10 — 3 months, dose 3
Symptoms: Tested positive for covid 19 on 12/27/21. Sore throat Congestion (nose and throat mainly)- coughing up phlegm, blocks airway sometimes Loss of voice Headache Fever 99.8 that morning Nausea Ears hurt
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aphonia | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Obstructive airways disorder | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release